RobertSAlterMD
Oncology • Hackensack, NJGenitourinary Oncology, Head & Neck Cancer
Co-Chief of Urologic and Head & Neck Oncology at John Theurer Cancer Center
Dr. Alter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
92 Second Street
Hackensack, NJ 07601- Is this information wrong?
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1991 - 1994
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1988 - 1991
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1988
Certifications & Licensure
NY State Medical License 1989 - 2026
FL State Medical License 1997 - 2025
NJ State Medical License 1996 - 2025
PA State Medical License 2002 - 2017
CT State Medical License 1994 - 1997
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma Start of enrollment: 2009 Oct 01
- Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer Start of enrollment: 2013 Apr 01
- LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 33 citationsPhase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F McDermott, Mehmet A Bilen
Journal of Clinical Oncology. 2022-09-01 - 86 citationsRandomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D. Galsky, Amir Mortazavi, Matthew I. Milowsky, Saby George, Sumati Gupta
Journal of Clinical Oncology. 2020-04-09 - 22 citationsA phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy.Toni K. Choueiri, Michael B. Atkins, Tracy L. Rose, Robert S. Alter, Yawen Ju
Investigational New Drugs. 2021-01-28
Professional Memberships
- Member
- Member
Other Languages
- Hebrew
Hospital Affiliations
Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
Hackensack Meridian Health Palisades Medical CenterNorth Bergen, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
